How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

416 results for

Episodic Atrial Fibrillation Home Management

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Episodic Atrial Fibrillation Home Management

Episodic Atrial Fibrillation Home Management Episodic Atrial Fibrillation Home Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Episodic Atrial Fibrillation Home Management Episodic Atrial Fibrillation Home Management Aka: Episodic Atrial Fibrillation Home Management , Intermittent Atrial Fibrillation Pill in the Pocket , Paroxysmal Atrial Fibrillation Home Management From Related Chapters II. Indications Episodic Fewer than 12 episodes yearly III. Contraindications or other structural heart disease IV. Protocol (Initiated by Cardiology) Cardiologists prescribe agent (Tambicor) 200-300 mg (Rhythmol) 600 mg Patient

2018 FP Notebook

2. Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association

tachyarrhythmias , atrial high-rate episodes , subclinical atrial fibrillation , silent atrial fibrillation , and subclinical atrial tachyarrhythmias . The document was peer reviewed by official external reviewers representing experts in population-based, clinical, and translational research on AF. Definition of AF Burden In the simplest sense, AF burden refers to the amount of AF that an individual has. By considering AF burden, we regard AF as a quantitative entity and move beyond merely treating AF (...) on clinical risk factors, not on AF pattern. Similarly, both the EORP-AF (EURObservational Research Programme–Atrial Fibrillation) General Pilot Registry and the J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Registry demonstrated higher death rates with nonparoxysmal AF; however, in the multivariable Cox model, nonparoxysmal AF was not an independent predictor of death during follow-up. , In the Euro Heart Survey, paroxysmal AF had comparable risk for thromboembolic events

Full Text available with Trip Pro

2018 American Heart Association

3. Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care

blood clots to form, which may cause a stroke. Early detection of atrial fibrillation allows preventative treatment to be started, for example, oral anticoagulants to reduce the risk of stroke. 2.4 The abnormal electrical impulses that cause the condition can result in persistent, permanent or intermittent atrial fibrillation: permanent atrial fibrillation: atrial fibrillation is present all the time persistent atrial fibrillation: episodes last longer than 7 days (if left untreated) Lead-I ECG (...) devices for detecting symptomatic atrial fibrillation using single time point testing in primary care (DG35) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 5 of 40paroxysmal atrial fibrillation: intermittent episodes that usually last less than 2 days and stop without treatment. 2.5 Signs and symptoms of atrial fibrillation include feeling dizzy, being short of breath, feeling tired, having chest discomfort and heart

2019 National Institute for Health and Clinical Excellence - Diagnostics Guidance

4. Atrial Fibrillation ? Diagnosis and Management

, clinic pharmacy, and at home). References: 1. e-CPS [Internet]. Ottawa, ON: Canadian Pharmacists Association; 2014 [cited 2014/08/20]. 2. Health Canada Drug Product Database Product Monographs. Ottawa, ON: Health Canada; 2014 [cited 2014/08/20]. 3. e-Therapeutics [Internet]. Ottawa, ON: Canadian Pharmacists Association; 2014 [cited 2014/08/20]. BCGuidelines.ca: Atrial Fibrillation – Diagnosis and Management: Appendix G (2015) 4 (...) Atrial Fibrillation ? Diagnosis and Management Guidelines & Protocols Advisory Committee Atrial Fibrillation – Diagnosis and Management Effective Date: April 1, 2015 Scope This guideline provides recommendations for the diagnosis and management of atrial fibrillation (AF) including the primary prevention of stroke and transient ischemic attack (TIA) in adults aged =19 years. This guideline focuses primarily on non-valvular AF . This guideline is part of the BCGuidelines.ca – Stroke and Atrial

2015 Clinical Practice Guidelines and Protocols in British Columbia

5. Atrial Fibrillation (Focused Update)

Atrial Fibrillation (Focused Update) Accepted Manuscript 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation Craig T. January, MD, PhD, FACC, Chair, Writing Group, L. Samuel Wann, MD, MACC, FAHA, Vice Chair, Writing Group, Hugh Calkins, MD, FACC, FAHA, FHRS, Writing Group Member, Lin Y. Chen, MD, MS, FACC, FAHA, FHRS, Writing Group Member, Joaquin E. Cigarroa, MD, FACC, Writing Group Member, Joseph C. Cleveland, Jr., MD, FACC (...) the content, and all legal disclaimers that apply to the journal pertain.MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT January CT, et al. 2019 Focused Update on Atrial Fibrillation Page 1 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Developed in Collaboration With the Society of Thoracic

2019 American College of Cardiology

6. Management of acute atrial fibrillation in the emergency department: a systematic review of recent studies

Management of acute atrial fibrillation in the emergency department: a systematic review of recent studies Management of acute atrial fibrillation in the emergency department: a systematic review of recent studies Management of acute atrial fibrillation in the emergency department: a systematic review of recent studies Coll-Vinent B, Fuenzalida C, Garcia A, Martin A, Miro O CRD summary This review examined recent-onset atrial fibrillation in the emergency department and concluded that atrial (...) published in English or Spanish. Search terms were reported. Reference lists of eligible studies were handsearched. Study selection Eligible studies assessed the effectiveness and safety of sinus rhythm control treatments in patients with atrial fibrillation episodes of short duration (<48 hours) who presented at the emergency department. Outcomes of interest were time to conversion, length of stay in the emergency department, safety and relapses or readmissions. Studies were excluded if they were

2014 DARE.

7. 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter

Documents Guidelines 2014 AHA/ACC/HRS Guidelines for the Management of Patients With Atrial Fibrillation 2013 ACCF/AHA Guideline for Management of Heart Failure Statements 2013 Treatment of Atrial Fibrillation , 2012 AHA/ASA Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation: A Science Advisory for Healthcare Professionals 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation Recommended for Patient Selection (...) to the measure. Table 4. Revised Atrial Fibrillation Measures No. Care Setting Measure Title Rationale for Revisions PM-4 Outpatient CHA 2 DS 2 -VASc Risk Score Documented This measure was revised to reflect the update in the “2014 AHA/ACC/HRS Guideline for Management of Patients With Atrial Fibrillation” that recommends the use of the CHA 2 DS 2 -VASc score instead of the CHA 2 DS 2 . Additionally, this measure was revised to allow for a patient reason exception that reflects instances in which a patient

2016 American Heart Association

8. Blood & Clots Series: How do you choose an anticoagulant for stroke prevention in atrial fibrillation?

by , and uploaded by Rebecca Dang. References 1. Stiell IG, Scheuermeyer FX, Vadeboncoeur A, et al. CAEP Acute Atrial Fibrillation/Flutter Best Practices Checklist. C . 2018;20(03):334-342. doi: 2. Macle L, Cairns J, Leblanc K, et al. 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. Can J Cardiol . 2016;32(10):1170-1185. [ ] 3. Foley T, Krantz M. CHAD is Dead: Pragmatic Utility of the CHA2DS2-VASc Score in Non-Valvular Atrial (...) Blood & Clots Series: How do you choose an anticoagulant for stroke prevention in atrial fibrillation? Blood & Clots Series: How do you choose an anticoagulant for stroke prevention in atrial fibrillation? - CanadiEM Blood & Clots Series: How do you choose an anticoagulant for stroke prevention in atrial fibrillation? In , by Kerstin de Wit October 23, 2018 All the content from the Blood & Clots series can be found . CanMEDS Roles addressed : Expert, health advocate, communicator Case

Full Text available with Trip Pro

2018 CandiEM

9. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies (...) . By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society , MD, PhD, FACC , MD, MACC, FAHA , MD, FACC, FAHA , MD, FACC, FAHA, FHRS , MD, FACC , MD, FACC , MD, FACC, FHRS , MD, PhD, FAHA , MB, ChB

2014 American Heart Association

10. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you (...) are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society , MD, PhD, FACC , MD, MACC, FAHA , MD, FACC, FAHA , MD, FACC, FAHA, FHRS , MD, FACC , MD, FACC , MD, FACC, FHRS , MD, PhD, FAHA , MB, ChB, FACC, FAHA , MD, FACC, FHRS , MD, FACC, FAHA, FHRS , MD

2014 American Heart Association

11. Screening for Atrial Fibrillation: 2017 European Heart Rhythm Association (EHRA) Consensus Document

Management) the presence or absence of symptoms associated with AF were not associated with differences in the risk of stroke or death, taking into account differences in baseline clinical parameters. 26 The negative prognostic implications of asymptomatic AF emerged in the EurObservational Research Programme-Atrial Fibrillation (EORP-AF) Pilot General Registry, where asymptomatic AF was commonly associated with elderly age, high burden of co- morbidities, and high thromboembolic risks, with higher 1 (...) Screening for Atrial Fibrillation: 2017 European Heart Rhythm Association (EHRA) Consensus Document Screeningforatrialfibrillation:aEuropean HeartRhythmAssociation(EHRA)consensus documentendorsedbytheHeartRhythm Society(HRS),AsiaPacificHeartRhythm Society(APHRS),andSociedad LatinoamericanadeEstimulaci onCard iaca y Electrofisiolog ia(SOLAECE) GeorgesH.Mairesse 1 *(Chair,Belgium),PatrickMoran 2 (Ireland), IsabelleC.VanGelder 3 (TheNetherlands),ChristianElsner 4 (Germany), MartenRosenqvist 5

2017 Heart Rhythm Society

12. Atrial Fibrillation

Appendix 90 20 References 91 Abbreviations and acronyms ABC age, biomarkers, clinical history ACE angiotensin-converting enzyme ACS acute coronary syndromes AF atrial fibrillation AFFIRM Atrial Fibrillation Follow-up Investigation of Rhythm Management AFNET German Competence NETwork on Atrial Fibrillation AngII angiotensin II AHRE atrial high rate episodes APACHE-AF Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients (...) therefore be helpful to unmask atrial flutter. The management of atrial flutter is discussed in chapter 13.7. Left or right atrial macro re-entrant tachycardia is mainly found in patients after catheter ablation for AF, AF surgery, or after open heart surgery. 6. Classification of atrial fibrillation 6.1 Atrial fibrillation pattern In many patients, AF progresses from short, infrequent episodes to longer and more frequent attacks. Over time, many patients will develop sustained forms of AF. In a small

Full Text available with Trip Pro

2016 European Society of Cardiology

13. 2017 EHRA Device-Detected Subclinical Atrial Tachyarrhythmias: Definition, Implications, and Management

implantable electronic devices. Subclinical atrial fibrillaton (AF): atrial high-rate episodes (>6 minutes and _729 PCS /24 hours) or episode of PSC runs > _20 beats. Abbreviations and acronyms AF - atrial fibrillation AHRE – atrial high rate episode ASSERT – ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and atrial fibrillation Reduction atrial pacing Trial AT – atrial tachyarrhythmia AVB – atrioventricular block BEATS – Balanced Evaluation of Atrial Tachyarrhythmias (...) arrhythmias, AVB, use of antiarrhythmic drug, and presence of heart failure than those without AHRE. 5 Overall, the incidence of subclinical AT/AF is20% within 1 year of follow-up, but there have been no consistent predictors of SCAF in patients with PPMs and ICDs and without AF history. Symptoms during atrial fibrillation episodes Patient’ perceptions of arrhythmia symptoms are highly variable: this includes individual awareness of on-going tachyarrhythmia. Among pacemaker patients who are known

2017 Heart Rhythm Society

14. Management of Atrial Fibrillation

Management of Atrial Fibrillation MOH/P/PAK/259.12(GU)STATEMENT OF INTENT This guideline is meant to be a guide for clinical practice, based on the best available evidence at the time of development. Adherence to this guideline may not necessarily guarantee the best outcome in every case. Every health care provider is responsible for the management of his/her unique patient based on the clinical picture presented by the patient and the management options available locally. This guideline (...) Guidelines for Atrial Fibrillation marked a milestone in the evolution of clinical practice guidelines and the delivery of care in cardiology. Specifically, these guidelines assist physicians in clinical decision making by describing a range of generally acceptable approaches for the diagnosis, management, and prevention of AF. Clinical Issues eg: AF assessment, best treatment strategy for acute AF & reduce risk of adverse outcomes from AF, best long term treatment strategy, management of AF in specific

2012 Ministry of Health, Malaysia

15. Is Rhythm Control Better Than Rate Control for New-Onset Atrial Fibrillation in the Emergency Department?

Is Rhythm Control Better Than Rate Control for New-Onset Atrial Fibrillation in the Emergency Department? Systematic Review Snapshot TAKE-HOME MESSAGE In patients with new-onset atrial ?brillation and symptom onset within 48 hours, rhythm control is preferred over rate control if the patient is younger than 65 years. For patients with congestive heart failure, valvular heart disease, hypertension, or permanent atrial ?brillation, rate control remains the favored strategy. Is Rhythm Control (...) -quality trials (Table) were selected for their relevance to emergency physicians on the basis of a younger age pro?le, paroxysmal atrial ?brillation sub- type, and early presentation to health care providers within 7 days of symptom onset. 2-5 The Japanese Rhythm Management Trial for Atrial Fibrillation 5 trial holds the most relevance for the emergency department (ED), given the large number of patients younger than 65 years, its selection criteria closely mimicking an ED presentation of atrial

2015 Annals of Emergency Medicine Systematic Review Snapshots

16. Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation

Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02889562 Recruitment Status : Recruiting First Posted : September 5, 2016 Last

2016 Clinical Trials

17. Mobile Health Technology for Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices: The HUAWEI Heart study. (PubMed)

Mobile Health Technology for Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices: The HUAWEI Heart study. Low detection and nonadherence are major problems in current management approaches for patients with suspected atrial fibrillation (AF). Mobile health (mHealth) devices may enable earlier AF detection, and improved AF management.To investigate the effectiveness of AF screening in a large population-based cohort using smart device based photoplethysmography (PPG (...) ) technology, combined with a clinical care AF management pathway using a mHealth approach.AF screening was performed with smart devices using PPG technology (Huawei Technologies Co., Ltd., Shenzhen, China) which were made available for the population aged over 18 years across China. Monitoring for at least 14-days with a wristband (HONOR BAND 4) or wristwatch (HUAWEI WATCH GT, HONOR WATCH), was allowed. The patients with 'possible AF' episodes using the PPG algorithm were further confirmed by health

2019 Journal of the American College of Cardiology

18. Reversal of Atrial Substrate to Prevent Atrial Fibrillation Pilot Study

Reversal of Atrial Substrate to Prevent Atrial Fibrillation Pilot Study Reversal of Atrial Substrate to Prevent Atrial Fibrillation Pilot Study - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Reversal (...) of Atrial Substrate to Prevent Atrial Fibrillation Pilot Study (RASTA-AF) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03186976 Recruitment Status : Recruiting First Posted : June 14, 2017 Last Update Posted : August 16

2017 Clinical Trials

19. Episodic Atrial Fibrillation Home Management

Episodic Atrial Fibrillation Home Management Episodic Atrial Fibrillation Home Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Episodic Atrial Fibrillation Home Management Episodic Atrial Fibrillation Home Management Aka: Episodic Atrial Fibrillation Home Management , Intermittent Atrial Fibrillation Pill in the Pocket , Paroxysmal Atrial Fibrillation Home Management From Related Chapters II. Indications Episodic Fewer than 12 episodes yearly III. Contraindications or other structural heart disease IV. Protocol (Initiated by Cardiology) Cardiologists prescribe agent (Tambicor) 200-300 mg (Rhythmol) 600 mg Patient

2015 FP Notebook

20. Management of recent-onset atrial fibrillation and flutter in the emergency department

Society Consensus Conference: atrial fibrillation–etiology and initial investigation of atrial fibrillation. Can J Cardiol . 2005 ; 21 : 11B–14B | When AF terminates spontaneously within 7 days of recognized onset, it is designated paroxysmal; when sustained beyond 7 days, AF is designated persistent. This chapter will focus on those with symptomatic, recent-onset episodes of AF/AFL (either newly detected, recurrent paroxysmal, or recurrent persistent episodes), the most common arrhythmia managed (...) are made to cardiovert patients to sinus rhythm in the ED, either pharmacologically or electrically, and then discharge them home in sinus rhythm. x 15 Taylor, D.M., Aggarwall, A., Carter, M., Garewal, D., and Hunt, D. Management of new onset atrial fibrillation in previously well patients less than 60 years of age. Emerg Med Austral . 2005 ; 17 : 4–10 | | | , x 16 Raghavan, A.V., Decker, W.W., and Meloy, T.D. Management of atrial fibrillation in the emergency department. Emerg Med Clin N Am . 2005

2010 CPG Infobase

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>